Kolbaev Sergey N, Sharonova Irina N, Vorobjev Vladimir S, Skrebitsky Vladimir G
Brain Research Institute, Russian Academy of Medical Sciences, Moscow, Russia.
Neuropharmacology. 2002 Jun;42(7):913-21. doi: 10.1016/s0028-3908(02)00042-4.
The action of diuretic furosemide on the GABA(A) receptor was studied in acutely isolated Purkinje cells using the whole-cell recording and fast application system. Furosemide blocked stationary component of GABA-activated currents in a concentration-dependent manner with IC(50) value > 5 mM at -70 mV. The inhibition was rapid in the onset, fully reversible and did not require drug pre-perfusion. The termination of GABA and furosemide co-application was followed by transient increase in the inward current 'tail' current, which was not observed when furosemide was continuously present in the solution. The degree of furosemide block did not depend on GABA concentration. Furosemide block increased with membrane depolarization. Five millimolar furosemide depressed GABA currents by 32.4+/-1.3% at -70 mV and by 76.7+/-5.0% at +70 mV. Analysis of the voltage dependence of the block suggests that furosemide binds at the site located within GABA(A) channel pore with a dissociation constant of 5.3+/-0.5 mM at 0 mV and electric distance of 0.27. Our results provide evidence that furosemide interacts with Purkinje cell GABA(A) receptors (most probably composed of alpha1beta2/3gamma2 subunits) through a low affinity site located in channel pore and suggest that furosemide acts as a sequential open channel blocker, which prevents the dissociation of agonist while the channel is blocked.
利用全细胞记录和快速给药系统,在急性分离的浦肯野细胞中研究了利尿药呋塞米对GABA(A)受体的作用。呋塞米以浓度依赖性方式阻断GABA激活电流的稳态成分,在-70 mV时IC(50)值>5 mM。抑制作用起效迅速,完全可逆,且不需要药物预灌注。GABA和呋塞米共同给药终止后,内向电流“尾电流”会短暂增加,而当溶液中持续存在呋塞米时未观察到这种现象。呋塞米的阻断程度不依赖于GABA浓度。呋塞米的阻断作用随膜去极化而增强。5 mM呋塞米在-70 mV时使GABA电流降低32.4±1.3%,在+70 mV时降低76.7±5.0%。对阻断作用的电压依赖性分析表明,呋塞米结合于GABA(A)通道孔内的位点,在0 mV时解离常数为5.3±0.5 mM,电距离为0.27。我们的结果提供了证据,表明呋塞米通过位于通道孔内的低亲和力位点与浦肯野细胞GABA(A)受体(最可能由α1β2/3γ2亚基组成)相互作用,并表明呋塞米作为一种顺序性开放通道阻断剂,在通道被阻断时阻止激动剂解离。